VIRAX BIOLABS GROUP LTD (VRAX) Earnings History & Surprises

NASDAQ:VRAX • KYG9495L1251

0.2151 USD
+0.01 (+2.92%)
Last: Mar 5, 2026, 11:25 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

Past quarterly earnings results for VIRAX BIOLABS GROUP LTD (VRAX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateDec 13, 2022

Last Reported

Most Recent
Release DateN/A
PeriodQ2 / 2026
EPS Reported
EPS Surprise %
Revenue Surprise %

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2026 - - 1.6K - -68.00%
Q4 2025 -0.61 - 68.42% 1.4K - -98.25%
Q2 2025 - - 5K - -93.46%
Q4 2024 -1.94 - - 79.9K - 2,753.57%
Q2 2024 - - 76.5K - -
Q4 2023 - - 2.8K - -
Q4 2022 - - - -100.00%
Q2 2022 - - - -100.00%
Q4 2021 - - 123.8K - -
Q2 2021 - - 14K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

VRAX EPS Q2Q GrowthVRAX EPS Q2Q GrowthEPS Q2Q Growth Q4/25 20 40 60

Revenue Historical Q2Q growth and Acceleration

VRAX Revenue Q2Q GrowthVRAX Revenue Q2Q GrowthRevenue Q2Q Growth Q2/22 Q4/22 Q4/24 Q2/25 Q4/25 Q2/26 0 500 1K 1.5K 2K 2.5K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

Related analysis

VRAX Overview VRAX Technical Analysis Report VRAX Fundamental Analysis Report VRAX Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

VIRAX BIOLABS GROUP LTD / VRAX Earnings FAQ

Can you provide information on whether VIRAX BIOLABS GROUP LTD beat earnings estimates in the last quarter?

VIRAX BIOLABS GROUP LTD (VRAX) missed EPS estimates and missed revenue estimates in the most recent quarter.